KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Gilead Sciences (GILD) Other Gross PP&E Adjustments (2016 - 2026)

Gilead Sciences filings provide 17 years of Other Gross PP&E Adjustments readings, the most recent being $1.7 billion for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 6.11% to $1.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 billion, a 6.11% increase, with the full-year FY2025 number at $1.7 billion, up 6.11% from a year prior.
  • Other Gross PP&E Adjustments hit $1.7 billion in Q4 2025 for Gilead Sciences, down from $8.2 billion in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $8.2 billion in Q3 2025 to a low of -$1.8 billion in Q1 2023.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$441.0 million (2021), compared with a mean of $1.3 billion.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 56.94% in 2021 and later skyrocketed 56.05% in 2024.
  • Gilead Sciences' Other Gross PP&E Adjustments stood at $814.0 million in 2021, then rose by 15.11% to $937.0 million in 2022, then grew by 11.95% to $1.0 billion in 2023, then skyrocketed by 56.05% to $1.6 billion in 2024, then grew by 6.11% to $1.7 billion in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $1.7 billion (Q4 2025), $8.2 billion (Q3 2025), and $8.1 billion (Q2 2025) per Business Quant data.